Topic: Amgen Inc.

Medical Affairs Report Outlines Resource Needs For Group Success

Medical News Today - 18 hours ago
The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas...

Maine Creative Team Collaborates with Patrick Dempsey to Design Cycling Jersey

MaineToday.com - yesterday
It's all in a day's work for the creative team at Rinck Advertising to create print ads, web sites and television commercials. But the agency's ...

Regenicin Announces Press and Investor Conference, NASDAQ MarketSite, Times Square

Globe Newswire - yesterday
Regenicin, Inc. (OTCBB:WDSTD), a clinical-stage biotechnology company, announced today that it will hold a media and investor conference at the...

Does Amgen Pass Buffett's Test?

Motley Fool - yesterday
We'd all like to invest as successfully as the legendary Warren Buffett. He calculates return on invested capital (ROIC) to help determine whether...

Don't Let It Happen, Celgene

Motley Fool - 2 days ago
Many investors, especially during earnings season, seem to focus on the income statement. How much revenue was there? How much net income was...

One Step Closer to Worry-Free

Motley Fool - 3 days ago
Getting a drug approved may be a marathon, but the battle isn't over when the Food and Drug Administration slaps an approved stamp on the marketing...

Citigroup, Inc (NYSE: C) Reiterates “Buy” Rating on Amgen, Inc (NASDAQ: AMGN)

American Banking News - 15 days ago
Citigroup, Inc (NYSE: C) analysts maintained a “buy” rating on shares of Amgen, Inc (NASDAQ: AMGN) with a price target of $64.00 in a research note...

Deutsche Bank (NYSE: DB) Gives Amgen (NASDAQ: AMGN) “Hold” Rating.

American Banking News - 18 days ago
Deutsche Bank (NYSE: DB) gave Amgen (NASDAQ: AMGN) a “hold” rating and a $7.00 price target in a research note to investors on Monday.. . Amgen...

Amgen names Peacock chief financial officer

AP News - 51 days ago
Amgen taps Jonathan Peacock as chief financial officer, replacing interim CFO Michael KellyBiotechnology company Amgen Inc. said Thursday it named Jonathan M. Peacock chief financial officer, effective Sept. 1.He succeeds Michael A. Kelly, who has served

Drug safety data sends Affymax shares tumbling

AP News - 75 days ago
Affymax shares fall to lowest point in over 3 years on anemia drug's late-stage safety dataShares of Affymax fell to their lowest point in more than three years on Monday after the company reported safety data from ongoing late-stage studies of ...